Novel immunohistochemical marker, integrin αvβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis

Oncology Letters

Volumn 2, Issue 2, 2011, Pages 229-234

  Kitahashi, Tsukasa ^a   Yoshimoto, Mitsuyoshi ^a   Imai, Toshio ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Early stage; Integrin aV 3; N nitrosobis(2 oxopropyl)amine; Pancreatic ductal carcinoma; Syrian hamster

Indexed keywords

ALPHA ENOLASE; BIS(2 OXOPROPYL)NITROSAMINE; GALECTIN 1; GALECTIN 3; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; VITRONECTIN RECEPTOR;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; EARLY CANCER; EPITHELIUM CELL; FEMALE; HAMSTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS ISLET CELL HYPERPLASIA; PHENOTYPE; PROTEIN EXPRESSION; SPECIES DIFFERENCE; STROMA CELL;

EID: 79551615564     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.252     Document Type: Article

References (29)

1. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T and the Japanese Cancer Surveillance Research Group: Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 38: 641-648, 2008.
2. Michaud DS: Epidemiology of pancreatic cancer. Minerva Chir 59: 99-111, 2004.
3. Tsukuma H, Ajiki W, Ioka A and Oshima A: Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 36: 602-607, 2006.
4. De Braud F, Cascinu S and Gatta G: Cancer of pancreas. Crit Rev Oncol Hematol 50: 147-155, 2004.
5. 3 in pancreatic carcinoma: relation to MMP-2 acti- vation and lymph node metastasis. Pancreas 25: e30-e35, 2002.
6. Johnson SK, Ramani VC, Hennings L and Haun RS: Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109: 1811-1820, 2007.
7. Shen J, Person MD, Zhu J, Abbruzzese JL and Li D: Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64: 9018-9026, 2004.
8. Shimamura T, Sakamoto M, Ino Y, Shimada K, Kosuge T, Sato Y, Tanaka K, Sekihara H and Hirohashi S: Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas. Clin Cancer Res 8: 2570-2575, 2002.
9. Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM and Goldenberg DM: New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol 24: 252-258, 2006.
10. Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, Tajika M, Yatabe Y, Matsuo K, uehara R, Ono K, Nakamura Y and Yamao K: Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol 45: 52-59, 2010.
11. Rivera JA, Graeme-Cook F, Werner J, Z'graggen K, Rustgi AK, Rattner DW, Warshaw AL and Fernández-del Castillo C: A rat model of pancreatic ductal adenocarcinoma: targeting chemical carcinogens. Surgery 122: 82-90, 1997.
12. Osvaldt AB, Wendt LR, Bersch VP, de Cássia A, Schumacher R, Edelweiss MI and Rohde L: Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice. Surgery 140: 803-809, 2006.
13. Pour P, Althoff J, Kruger FW and Mohr U: A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine. J Natl Cancer Inst 58: 1449-1453, 1977.
14. Hingorani SR, Petricoin EF, Maitra A, et al: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450, 2003.
15. Ueda S, Fukamachi K, Matsuoka Y, Takasuka N, Takeshita F, Naito A, Iigo M, Alexander DB, Moore MA, Saito I, Ochiya T and Tsuda H: Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Carcinogenesis 27: 2497-2510, 2006.
16. Fujii H, Egami H, Chaney W, Pour P and Pelling J: Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog 3: 296-301, 1990.
17. Li J, Weghorst CM, Tsutsumi M, Poi MJ, Knobloch TJ, Casto BC, Melvin WS, Tsai MD and Muscarella P: Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancre- atic tumors. Carcinogenesis 25: 263-268, 2004.
18. Tsujiuchi T, Sasaki Y, Kubozoe T, Konishi Y and Tsutsumi M: Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters. Mol Carcinog 36: 60-66, 2003.
19. Konishi Y, Mizumoto K, Kitazawa S, Tsujiuchi T, Tsutsumi M and Kamano T: Early ductal lesions of pancreatic carcinogenesis in animals and humans. Int J Pancreatol 7: 83-89, 1990.
20. Roda O, Chiva C, Espuna G, Gabius H, Real FX, Navarro P and Andreu D: A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. Proteomics 6: S36-S41, 2006.
21. 3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1. Int J Cancer 63: 530-536, 1995.
22. 6 on cell proliferative responses to tenascin. Roles of the β subunit extracellular and cytoplasmic domains. J Biol Chem 271: 24144-24150, 1996.
23. 18F-Galacto-RGD PET. J Nucl Med 49: 255-259, 2008.
24. Hansson L, Strömqvist M, Bäckman A, Wallbrandt P, Carlstein A and Egelrud T: Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 269: 19420-19426, 1994.
25. Barondes SH, Castronovo V, Cooper DN, et al: Galectins: a family of animal β-galactoside-binding lectins. Cell 76: 597-598 1994.
26. Perillo, NL, Marcus ME and Baum LG: Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 76: 402-412, 1998.
27. Maeda N, Kawada N, Seki S, Ikeda K, Iwao H, Okuyama H, Hirabayashi J, Kasai K and Yoshizato K: Stimulation of prolif- eration of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Chem 278: 18938-18944, 2003.
28. Zhou W, Capello M, Fredolini C, Piemonti L, Liotta LA, Novelli F and Petricoin EF: Mass spectrometry analysis of the post-translational modifications of α-enolase from pancreatic ductal adenocarcinoma cells. J Proteome Res 9: 2929-2936, 2010.
29. Ahmed M and Bergsten P: Glucose-induced changes of multiple mouse islet proteins analysed by two-dimensional gel elec- trophoresis and mass spectrometry. Diabetologia 48: 477-485, 2005.